FEMY vs MSCI · rev $756.7K vs P/E 37, rev $1.72B
Femasys Inc (FEMY) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported FEMY revenue for 2026-06-30 was $756.7K. Net income was -$3.6M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. FEMY currently screens at market cap $925.2K.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
FEMY currently screens at market cap $925.2K. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the FEMY and MSCI stock pages for the full models.
Not investment advice.